Jonathan Siegel

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

Jeffrey S. Weber, John A. Thompson, Omid Hamid et al. · Clinical Cancer Research · 2009 · 567 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

David M. Berman, Susan Parker, Jonathan Siegel et al. · PubMed · 2010 · 227 citations · Full text

Medicine, Immunology, Oncology +17

Safety and clinical activity of ipilimumab in melanoma patients with brain metastases

Jeffrey S. Weber, Asim Amin, David R. Minor et al. · Melanoma Research · 2011 · 112 citations

Medicine, Clinical Sciences, Oncology +17

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial

Hedy L. Kindler, Silvia Novello, Alessandra Bearz et al. · The Lancet Oncology · 2022 · 68 citations · Full text

Medicine, Oncology, Pharmacology +12

Estimating The Mission-Related Costs Of Teaching Hospitals

Lane Koenig, Allen Dobson, Silver Ho et al. · Health Affairs · 2003 · 64 citations

Public Affairs, Health Administration, Medical Education +17